|Videos|May 17, 2021
Deep Dive: Deep Dive Into New Presbyopia Therapies
Author(s)Ophthalmology Times
Two new therapies for presbyopia are in the pipeline. Allergan recently submitted an NDA for its investigational eye drop to treat the condition, and Visus Therapeutics recently received FDA acceptance of its investigational new drug application for Brimochol. Dr. Michael Robinson from Allergan and Dr. Rhett Schiffman from Visus join Deep Dive to talk about how the products work and what’s coming next.
Related Articles
- Deep Dive: Into AI Tech and Coughing
June 19th 2023
- Behind the Science: Behind AI in Colorectal Cancer
May 17th 2023
- Deep Dive: Into the Rise of AI in Oncologic Care
May 17th 2023
- Deep Dive: Into ChatGPT and Generative AI
April 28th 2023
- Behind the Science: Behind ChatGPT in Radiology
April 27th 2023
- Deep Dive: Into Psychedelic Treatments
April 14th 2023